Table: Zeria Pharm -6-MTH group results

Zeria Pharmaceutical

04/11/2015 07:00

Nov 4 (Reuters)-  
             Zeria Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             30.34               30.14            65.00     
                 (+0.7 pct)          (+0.1 pct)       (+6.5 pct)   
  Operating          2.11                2.28             4.50     
                 (-7.2 pct)          (-43.9 pct)      (+68.0 pct)  
  Recurring          1.58                2.24             4.10     
                 (-29.3 pct)         (-46.9 pct)      (+48.0 pct)  
  Net                1.62                2.12             3.30     
                 (-23.6 pct)         (-36.6 pct)      (+29.0 pct)  
  EPS             30.44 yen           39.83 yen        62.13 yen   
  Ann Div                             30.00 yen        30.00 yen   
  -Q2 div         15.00 yen           15.00 yen                    
  -Q4 div                             15.00 yen        15.00 yen   
   
  NOTE - Zeria Pharmaceutical Co Ltd is a medium-size pharmaceutical maker, strong in prescription drugs.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T  
  ((Tokyo Headline News Desk +813 6441 1812))